Adjuvant Celecoxib in Completely Resected pN1-2 NSCLC Patients

This study has suspended participant recruitment.
Sponsor:
Collaborators:
Central and Eastern European Oncology Group
Stowarzyszenie Ludzi Wyleczonych z Raka Płuca
Pharmacia
Information provided by:
Medical University of Gdansk
ClinicalTrials.gov Identifier:
NCT00211952
First received: September 13, 2005
Last updated: NA
Last verified: September 2005
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has suspended participant recruitment.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given